FDAFDA · Food and drugs·Recall number D-1152-2022
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Published June 29, 2022 · Recall initiated: June 9, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLONIDINE
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Nationwide in the US Market
- Lot
- Lot: 41179A Exp. Jan 2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.